Molecular biomarkers in uterine sarcomas: a review of reviews with genomic data integration.
BACKGROUND Uterine sarcomas (US) account for 3-7% of uterine malignancies but cause disproportionate high cancer-related mortality. Despite expanding molecular profiling, evidence remains fragmented across histological categories, limiting translation into validated prognostic tools and actionable therapeutic targets....